A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response
暂无分享,去创建一个
C. Schmitt | M. Hummel | J. Kase | I. Anagnostopoulos | Sophy Denker | Il-Kang Na | M. Frick | A. Bittner | Mareike Frick